Tumors Associated With Neurofibromatosis Type 1: Precision Medicine Approaches to Improve Patient Outcomes Across All Age Groups

CME-certified on-demand webcast and downloadable slidesets from a live symposium featuring expert perspectives on MEK inhibition for the treatment of NF1-associated plexiform neurofibromas in pediatric and adult patients.

Share

Program Content

Activities

NF1 Call to Action
Call to Action: What to Know About Caring for Adult and Pediatric Patients With Inoperable Neurofibromatosis Type 1-Associated Tumors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 09, 2023

Activities

NF1 Webcast
Precision Medicine in Tumors Associated With Neurofibromatosis Type 1
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2023

Expires: November 29, 2024

Activities

NF1 Overview
NF1: Current State of Disease Understanding
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

NF1 PNST
NF1-Associated Peripheral Nerve Sheath Tumors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

NF1 LGG
NF1-Associated Low-Grade Gliomas
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an educational grant from Alexion Pharmaceuticals.

Alexion Pharmaceuticals